GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Abstract BACKGROUND Biosimilars are biologic products similar in safety and efficacy to the originator product. Tumor necrosis factor-alpha inhibitors (anti-TNFs) are used in the treatment of inflammatory bowel diseases (IBD). There are limited studies evaluating the long-term outcomes of anti-TNF b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Inflammatory bowel diseases 2023-01, Vol.29 (Supplement_1), p.S61-S62
Hauptverfasser:	McClinchie, Madeline, Lakhani, Alyshah, Abdel-Rasoul, Mahmoud, McNicol, Megan, Shaikhkhalil, Ala, Boyle, Brendan, Maltz, Ross
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!